Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of ANG-3777 in Patients Hospitalized With Confirmed COVID-19 Pneumonia
NCT04459676Phase 2Unknown
- Sponsor
- Angion Biomedica Corp.
- Start
- Jul 2020
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of terevalefim in COVID-19 pneumonia, sponsored by Angion Biomedica Corp.. Status: unknown.
02
Drugs
terevalefim
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT04459676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04459676.